摘要
Background: Liver kinase B1 (LKB1) is the key regulator of energy metabolism and cell homeostasis. LKB1 dysfunction plays a key role in renal fibrosis. However, LKB1 activators are scarce in commercial nowadays. This study aims to discover a new drug molecule, piericidin analogue S14 (PA-S14), preventing renal fibrosis as a novel activator to LKB1.Methods: Our group isolated PA-S14 from the broth culture of a marine-derived Streptomyces strain and identified its binding site. We adopted various CKD models or AKI-CKD model (5/6 nephrectomy, UUO, UIRI and adriamycin nephropathy models). TGF-beta-stimulated renal tubular cell culture was also tested.Results: We identified that PA-S14 binds with residue D176 in the kinase domain of LKB1, and then induces the activation of LKB1 through its phosphorylation and complex formation with MO25 and STRAD. As a result, PA-S14 promotes AMPK activation, triggers autophagosome maturation, and increases autophagic flux. PA-S14 inhibited tubular cell senescence and retarded fibrogenesis through activation of LKB1/AMPK signaling. Transcriptomics sequencing and mutation analysis further demonstrated our results.Conclusion: PA-S14 is a novel leading compound of LKB1 activator. PA-S14 is a therapeutic potential to renal fibrosis through LKB1/AMPK-mediated autophagy and mitochondrial homeostasis pathways.
学科与关键词
- AMPK Activator O304 Protects Against Kidney Aging Through Promoting Energy Metabolism and AutophagyZhu, Mingsheng; Shen, Weiwei; Li, Jiemei; Jia, Nan; Xiong, Yabing; Miao, Jinhua; Xie, Chao; Chen, Qiyan; Shen, Kunyu; Meng, Ping; Li, Xiaolong; Wu, Qinyu; Zhou, Shan; Wang, Maosheng*; Kong, Yaozhong*; Zhou, Lili*Frontiers in Pharmacology, 2022, 13: 836496.被引 9
- Penicilliumin B Protects against Cisplatin-Induced Renal Tubular Cell Apoptosis through Activation of AMPK-Induced Autophagy and Mitochondrial BiogenesisShen, Weiwei; Jia, Nan; Miao, Jinhua; Chen, Shuangqin; Zhou, Shan; Meng, Ping; Zhou, Xuefeng; Tang, Lan; Zhou, Lili*Kidney Diseases, 2021, 7(4): 278-292.被引 5
- Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney diseaseSong, Xuewen; Tsakiridis, Evelyn; Steinberg, Gregory R.; Pei, York*Cellular Signalling, 2020, 73: 109704.被引 23
